Current BOD will be ousted at ASM
1. Wall Street wants RESULTS.
2. Current BOD has not delivered.
3. 30% withhold confidence votes for current BOD at past ASMs, even before we ever heard of Ronin.
4. Given the publication of excessive salaries (bigger than Merck and Gilead directors), withhold votes will skyrocket at 2017 ASM.
5. We can debate Ronin's motives here quite a bit, (and many good points have been made), but it doesn't matter.
6. The current BOD will be ousted come October, 2017.
7. The only way we could get back to our dream of "astronomical values" would be a stock price of $300-500 pps.
8. Ask yourself how feasible that is, given "no skin" in the game for our directors, Myford expansion on ice, still losing money, and no reserves to advance Bavi trials.
9. Everything, and I mean EVERYTHING hangs on the NCCN, head and neck trial combining Keytruda and Bavi.
10. Results from that trial are YEARS away.
11. We can debate extensively here about Ronin, but a new Board is essentially a done deal at this point.
12. Does Bavi still have potential? Of course it does. Great potential. But the company has been so poorly run for so many years, it's time to set the house in order.
13. Get the company on a solid financial footing. Of course the company has potential. UNREALIZED potential.
14. Many good posters here have "separation anxiety." I understand. But reality check. Are the trailing zeros on your online brokerage account increasing or decreasing?
15. Ronin states they are not raiders and their prior story supports that claim.
16. Yes, these are precarious times, but thats "just what the doctor ordered" for PPHM.
17. Did we need a wake-up call? YES.
18. Avoid normalcy bias. Many think Ronin will raid and sell. Others think the BOD will do a great job with Bavi in the future.
19. In reality, something different will happen. If there's one guarantee, that's it.
20. Many have used up all their patience. October is almost upon us. Big changes are coming. That's a good thing.
Best,
Joe Six Pack
